Identification of two novel TP53 mutations in secondary acute myeloid leukemia following multiple myeloma: a case report

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Integrating p53-associated genes and infiltrating immune cell characterization as a prognostic biomarker in multiple myeloma2024 · 3 citations
2. 2<i>TP53</i> Mutations in Acute Leukemias and Myelodysplastic Syndromes: Insights and Treatment Updates2024 · 38 citations
3. 3Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome AtlasOriginal Research · 2019 · 158 citations
4. 4Lenalidomide promotes the development of <i>TP53</i>-mutated therapy-related myeloid neoplasmsOriginal Research · 2022 · 136 citations
5. 5<i>TP53</i> copy number and protein expression inform mutation status across risk categories in acute myeloid leukemiaPrognostic Study · 2022 · 114 citations